Skip to main content

Advertisement

Log in

Cholestatic Jaundice in Sulphite Oxidase Deficiency – An Unusual Association

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Sulphite oxidase deficiency is an extremely rare inborn error of metabolism of sulphur containing amino acids. There are no reports of liver involvement in this condition. The authors describe a 9-y-old boy with known sulphite oxidase deficiency who presented with worsening cholestatic hepatitis which may be possibly related to underlying metabolic disorder. Although there is no current evidence that treating liver disease and ensuring normal hepatic function in sulphite oxidase deficiency would likely benefit patients, this could potentially contribute to optimising growth and development as well as improving the overall prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bindu PS, Nagappa M, Bharath RD, Taly AB. Isolated sulfite oxidase deficiency. 2017 Sep 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK453433/

  2. Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, Vol 2. 8th ed. New York: McGraw-Hill; 2001. p. 3163–77.

    Google Scholar 

  3. Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Handbook of experimental pharmacology, bile acids and their receptors, vol. 256. Berlin: Springer-Verlag; 2019. p. 237–64.

  4. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36:525–31.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Dimple Rajgor for her assistance in formatting, reviewing, and in submitting the manuscript for publication.

Author information

Authors and Affiliations

Authors

Contributions

ASKO: Collected the data, carried out the initial analyses, drafted and revised the manuscript. MMA and DL-MG: Conceptualized and designed the study and critically reviewed the manuscript for important intellectual content; SVK: Conceptualized and designed the study, interpreted the data and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. SVK is the guarantor for this paper.

Corresponding author

Correspondence to Sivaramakrishnan Venkatesh Karthik.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ong, A.S.K., Aw, M.M., Goh, D.LM. et al. Cholestatic Jaundice in Sulphite Oxidase Deficiency – An Unusual Association. Indian J Pediatr 88, 64–66 (2021). https://doi.org/10.1007/s12098-020-03428-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-020-03428-3

Keywords

Navigation